Transforming the Prevention, Diagnosis, and Treatment of Kidney Disease

Transforming the Prevention and Diagnosis of Kidney Disease


“For too long we’ve resigned to accept the status quo for the treatment of kidney disease.”


-Bruce Greenstein, U.S. Department of Health & Human Services (HHS) Chief Technology Officer

Chronic Kidney Disease, or CKD, is a global public health crisis. 1 out of 9 people worldwide have CKD. In the United States, that number is 1 out of 6.

In the U.S., $30 billion is spent by Medicare on CKD and End-Stage Renal Disease.


While early detection saves money and increases therapeutic options, diagnostics to detect early kidney injury did not exist.

Until now.

The KIT Assay and Score provides a quantitative measure of kidney injury, detecting injury in its earliest stages and providing a risk score that enables clinicians to intervene.